This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) JMIR Theme Issue: COVID-19 Special Issue (2452)

Published on in Vol 9, No 12 (2020): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23830, first published .
Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Authors of this article:

Junko Terada-Hirashima1 Author Orcid Image ;   Manabu Suzuki1 Author Orcid Image ;   Yukari Uemura2 Author Orcid Image ;   Masayuki Hojo1 Author Orcid Image ;   Ayako Mikami2 Author Orcid Image ;   Wataru Sugiura2 Author Orcid Image ;   Norio Ohmagari3 Author Orcid Image ;   Haruhito Sugiyama1 Author Orcid Image
Article Authors Cited by (15) Tweetations (13) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.